Deciding whether to have a breast reconstructed after surgery to remove breast cancer is a very personal choice. Researchers are studying how different reconstruction techniques, as well as the timing of reconstruction, affect reconstruction outcomes, both emotionally and physically.
There are three ways to time reconstruction after mastectomy:
There are two main techniques for reconstructing the breast:
The small study reviewed here found that poor outcomes or severe complications were more likely with immediate implant reconstruction followed by radiation therapy than with immediate autologous reconstruction followed by radiation therapy. Most of the women in the study who choose autologous reconstruction had a TRAM flap. TRAM stands for the transverse rectus abdominis muscle, which is in the lower abdomen, between the waist and the pubic bone. With the TRAM procedure a "flap" of this abdominal tissue is moved to the chest area to reconstruct the breast.
If you're considering breast reconstruction, talk to your doctor about the options that make the most sense for you. Here are some sample questions you might want to ask:
Visit the Breastcancer.org Reconstruction section to learn much more about reconstruction options you and your doctor can consider.
GARDEN CITY, N.Y., Nov. 21 (MedPage Today) -- For women who've had breast reconstruction immediately after mastectomy, the type of procedure may determine outcomes following radiation, researchers found.
The rate of severe complications requiring surgical intervention or IV antibiotics was significantly higher for women who had tissue expander and implant reconstruction than for those whose new breast was constructed using autologous tissue (33.3% versus 0%, P=0.001), according to Jigna Jhaveri, M.D., of Long Island Radiation Therapy here, and colleagues.
Women undergoing tissue expander and implant reconstruction were also significantly more likely to have poor functional results (55% versus 8.7%, P<0.001), they reported in the Nov. 1 issue of the International Journal of Radiation Oncology Biology Physics.
And patients who had autologous tissue reconstruction were more likely to rate the cosmetic result as acceptable (82.5% versus 51%, P=0.007), the researchers said.
"We believe that this report provides important information to help patients in choosing a reconstructive technique that may suit them best," they said.
Undergoing immediate reconstruction can complicate planning for radiation therapy and, alternately, radiation can negatively affect clinical outcomes of the reconstruction, the researchers said.
Most previous studies evaluating outcomes following post-mastectomy breast reconstruction and radiation therapy have been subject to various limitations, they said.
So they retrospectively analyzed data from 92 patients who had had a radical mastectomy, immediate reconstruction, and radiation therapy at their practice from 1998 through 2005.
Three-quarters of the patients underwent tissue expander and implant reconstruction, and the rest had autologous tissue reconstruction, mostly using a tissue flap from the transverse rectus abdominus muscle.
All patients received 50.4 Gy of radiation to the reconstructed breast and chest wall and 45 Gy to the supraclavicular region; 18% received a boost greater than 50.4 Gy.
Patients who had the autologous tissue procedure were significantly younger (median age 46 versus 54, P=0.04), but received similar treatment.
Most of the patients (95%) received primarily doxorubicin-based chemotherapy, and 76% received hormonal therapy after radiation therapy was completed.
Through a median follow-up of 38 months, the overall rates of poor functional results and severe complications were 43.4% and 25%, respectively, although both were significantly higher in patients who had the tissue expander procedure.
Severe complications found in the patients who underwent the tissue expander procedure included severe capsular contracture requiring revision and infection requiring IV antibiotics.
Fourteen patients, all in the tissue expander group, had their implants removed because of unacceptable cosmetic result (six), infection (seven), or cancer recurrence (one).
Aside from type of reconstruction, no treatment- or patient-related factors were significantly associated with clinical outcome.
The authors acknowledged that the study was limited by the retrospective design and by the lack of information regarding the timing of the exchange of the tissue expander for a permanent implant.
The authors reported no conflicts of interest.
Primary source: International Journal of Radiation Oncology Biology Physics Source reference: Jhaveri J, et al "Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction" Int J Radiation Oncology Biol Phys 2008; 72: 859-865.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
©2011 Breastcancer.org - All rights reserved.